Skip to main content
. 2013 Mar-Apr;6(2):73–83.

Table 5.

Percentage of Patients with Fragile X Syndrome Prescribed Psychotropic Medications

Drug Commercial/Medicare Medicaid
Children, % (n = 354) Adolescents, % (n = 150) Adults, % (n = 280) Total, % (N = 784) Children, % (n = 302) Adolescents, % (n = 120) Adults, % (n = 299) Total, % (N = 721)
Antidepressants
Sertraline hydrochloride 3.7 10.0 6.8 6.0 2.0 10.0 9.0 6.2
Fluoxetine hydrochloride 2.0 6.7 3.6 3.4 2.3 5.9 5.0 4.0
Escitalopram oxalate 1.1 4.0 5.4 3.2 0.7 3.3 3.7 2.4
Citalopram hydrobromide 1.4 5.3 2.1 2.4 1.7 0.0 4.7 2.6
Paroxetine hydrochloride 0.6 4.0 2.9 2.0 2.0 2.5 6.0 3.7
Bupropion hydrochloride 0.6 0.0 4.6 1.9 0.0 3.3 2.3 1.5
Venlafaxine hydrochloride 0.0 1.3 4.3 1.8 0.0 1.7 2.7 1.4
Trazodone hydrochloride 0.0 2.0 2.5 1.3 0.3 4.2 3.3 2.2
Antipsychotic agents
Risperidone 4.0 8.0 4.3 4.9 10.3 20.8 15.1 14.0
Aripiprazole 4.0 8.7 2.9 4.5 1.7 8.3 5.4 4.3
Quetiapine fumarate 0.9 4.0 2.9 2.2 0.7 6.7 7.7 4.6
Stimulants
Methylphenidate hydrochloride 7.9 19.3 5.4 9.2 9.9 15.0 6.7 9.4
Dexmethyl-phenidate hydrochloride 3.7 2.0 1.1 2.4 3.3 1.7 0.3 1.8
Lisdexamfetamine dimesylate 1.1 2.7 0.0 1.0 0.0 1.7 0.0 0.3
Miscellaneous
Clonidine 2.6 8.0 1.8 3.3 9.6 19.2 7.7 10.4
Guanfacine 2.6 6.7 1.4 2.9 3.0 1.7 1.0 1.9
Minocycline 0.0 2.7 2.9 1.5 0.7 0.0 1.0 0.7
Lithium carbonate 0.0 0.0 0.7 0.3 0.0 0.8 1.7 0.8